AFSSI – The French association of outsourcing and innovative companies Olivier LOGET, CapEval Pharma Managing Director and and board member of AFSSI, has more than 35 years of experience in pharmaceutical research and development. He worked in research departments since 1987 at Sanofi (Paris area), charles River (Lyon), CIT (Evreux), Roche (Basel), Addex Therapeutics (Geneva), OriBase Pharma (Montpellier) and CapEval Pharma (Geneva area). He is a Eurotox Registered Toxicologist with great expertise in drug research and discovery. He joined Addex Therapeutics (Geneva) in 2006 as Head of Non-Clinical Drug Safety to participate in the IPO and to create, develop and lead this research department until 2010, when he created CapEval Pharma and OriBase Pharma and became CSO of OriBase Pharma. As OriBase Pharma Scientific Director (anticancer drug research), he brought a great expertise in oncology drug discovery and research from candidate selection to clinical trials. At Roche he was Head of Animal Experimentation and Research Toxicology Project Leader. He was involved in several research projects and Due Siligence opportunity assessment.
He founded in 2010 CapEval Pharma, which he leads. He obtained his degree and doctorate in Veterinary Medicine at the University of Nantes (1990). He is author or co-author of more than 20 publications. He is co-founder of the European Society of Laboratory Animal Veterinarians and president of the International Society of Ocular Toxicology. He is a lecturer teaching preclinical R&D, toxicology in drug development and ocular examination in several Research Institutes (INSERM, INRA), International Universities and Veterinary Schools.
